Results overview: Found 4 records in 0.01 seconds.
Articles, 4 records found
Articles 4 records found  
1.
14 p, 572.1 KB Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer / Frigola Rissech, Joan (VHIO) ; Navarro, Alejandro (VHIO) ; Carbonell, Caterina (VHIO) ; Callejo, Anna (VHIO) ; Iranzo, Patricia (VHIO) ; Cedrés, Susana (VHIO) ; Martinez-Martí, Alex (VHIO) ; Pardo, Nuria (VHIO) ; Saoudi-Gonzalez, Nadia (VHIO) ; Martinez, D. (Translational Genomics and Targeted Therapies in Solid Tumors. IDIBAPS) ; Jiménez, José (VHIO) ; Sansano, Irene (Hospital Universitari Vall d'Hebron) ; Mancuso, Francesco M. (VHIO) ; Nuciforo, Paolo (VHIO) ; Montuenga, L.M. (Navarra Health Research Institute (IDISNA)) ; Sánchez-Cespedes, Montse (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Prat, A. (Translational Genomics and Targeted Therapies in Solid Tumors. IDIBAPS) ; Vivancos, Ana (VHIO) ; Felip, Enriqueta (VHIO) ; Amat, Ramón (VHIO) ; Universitat Autònoma de Barcelona
Immunotherapy has transformed advanced non-small cell lung cancer (NSCLC) treatment strategies and has led to unprecedented long-lasting responses in some patients. However, the molecular determinants driving these long-term responses remain elusive. [...]
2020 - 10.1002/1878-0261.12891
Molecular Oncology, 2020  
2.
9 p, 559.7 KB Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients / Sesé, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Somoza, Rosa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Maestu, Inmaculada (Hospital Universitario Doctor Peset. Department of Medical Oncology) ; Ureste, Maria Martín (Hospital Universitario Doctor Peset. Department of Medical Oncology) ; Sanchez, Alfredo (Department of Medical Oncology, Consorci Hospitalari Provincial de Castelló, Castellón, Spain) ; Cordoba, Juan Felipe (Hospital Universitari Arnau de Vilanova. Department of Medical Oncology) ; Sansano, Irene (Hospital Universitari Vall d'Hebron) ; Venturas, Griselda (Hospital Universitari Vall d'Hebron) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernandez-Losa, Javier (Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain) ; Universitat Autònoma de Barcelona
Precision medicine has revolutionized the understanding and treatment of cancer by identifying subsets of patients who are amenable to specific treatments according to their molecular characteristics, as exemplified by epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). [...]
2019 - 10.1007/s40487-019-00099-9
Oncology and Therapy, Vol. 7 (august 2019) , p. 131-139  
3.
13 p, 2.1 MB Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma : the ROSING Study / Conde, E. (HM Sanchinarro University Hospital-CIBERONC) ; Hernández, Susana (HM Sanchinarro University Hospital) ; Martinez, R. (HM Sanchinarro University Hospital) ; Angulo, B. (HM Sanchinarro University Hospital-CIBERONC) ; De Castro, J. (La Paz University Hospital) ; Collazo-Lorduy, A. (HM Sanchinarro University Hospital) ; Jimenez, B. (HM Sanchinarro University Hospital) ; Muriel, A. (Ramon y Cajal University Hospital. IRYCIS and CIBERESP) ; Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Aranda, I. (General University Hospital-ISABIAL) ; Massuti, B. (General University Hospital-ISABIAL) ; Rojo, F. (Institute of Health Research-Jimenez Diaz Foundation-CIBERONC) ; Domine, M. (Institute of Health Research-Jimenez Diaz Foundation) ; Sansano, Irene (Hospital Universitari Vall d'Hebron) ; Garcia, F. (Quironsalud Hospital) ; Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ; Mancheño, N. (La Fe University Hospital) ; Juan, O. (La Fe University Hospital) ; Sanz, Julián (Clinico San Carlos University Hospital) ; Gonzalez-Larriba, J.L. (Clinico San Carlos University Hospital) ; Atienza-Cuevas, L. (Puerta del Mar University Hospital) ; Arriola-Arellano, E. (Puerta del Mar University Hospital) ; Abdulkader, I. (Clinico de Santiago University Hospital) ; Garcia-Gonzalez, J. (Clinico de Santiago University Hospital) ; Camacho, C. (Insular Materno-Infantil University Hospital Complex) ; Rodriguez-Abreu, D. (Insular Materno-Infantil University Hospital Complex) ; Teixido, C. (Clinic Hospital) ; Reguart, Noemí (Clinic Hospital) ; Gonzalez-Piñeiro, A. (Alvaro Cunqueiro Hospital) ; Lazaro-Quintela, M. (Alvaro Cunqueiro Hospital) ; Lozano, M.D. (University of Navarra Clinic) ; Gurpide, A. (University of Navarra Clinic) ; Gomez-Roman, J. (Marques de Valdecilla University Hospital) ; Lopez-Brea, M. (Marques de Valdecilla University Hospital) ; Pijuan, Lara (Hospital del Mar) ; Salido, Marta (Hospital del Mar) ; Arriola, Edurne (Hospital del Mar) ; Company, A. (Clinico University Hospital) ; Insa, A. (Clinico University Hospital) ; Esteban-Rodriguez, I. (La Paz University Hospital) ; Saiz, M. (Cruces University Hospital) ; Azkona, E. (Cruces University Hospital) ; Alvarez, R. (Miguel Servet University Hospital) ; Artal, A. (Miguel Servet University Hospital) ; Plaza, M.L. (University Hospital of Gran Canaria Doctor Negrin) ; Aguiar, D. (University Hospital of Gran Canaria Doctor Negrin) ; Enguita, A.B. (12 de Octubre University Hospital) ; Benito, A. (Ramon y Cajal University Hospital) ; Paz-Ares, L. (12 de Octubre University Hospital-CIBERONC) ; Garrido, P. (Ramon y Cajal University Hospital-CIBERONC) ; Lopez-Rios, F. (HM Sanchinarro University Hospital-CIBERONC) ; Universitat Autònoma de Barcelona
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support the use of ROS1 immunohistochemistry (IHC) as a screening test, followed by confirmation with fluorescence in situ hybridization (FISH) or a molecular test in all positive results. [...]
2019 - 10.1016/j.jtho.2019.07.005
Journal of Thoracic Oncology, Vol. 14 Núm. 12 (december 2019) , p. 2120-2132  
4.
9 p, 5.6 MB Pleuroparenchymal Fibroelastosis : A New Entity within the Spectrum of Rare Idiopathic Interstitial Pneumonias / Portillo, Karina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Guasch, Ignasi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Becker, Caroline (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Andreo, Felipe (CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III) ; Fernández-Figueras, Maria Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ramirez Ruz, José (Hospital Clínic, Barcelona) ; Martinez-Barenys, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-Reina, Samuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Lopez de Castro, Pedro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sansano, Irene (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Villar, Ana (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ruiz Manzano, J (Universitat Autònoma de Barcelona. Departament de Medicina)
Pleuroparenchymal fibroelastosis (PPFE) is a rare entity that has been recently included in the official American Thoracic Society/European Respiratory Society (ATS/ERS) statement in 2013 as a group of rare idiopathic interstitial pneumonias (IIPs). [...]
2015 - 10.1155/2015/810515
Case Reports in Pulmonology, Vol. 2015 (august 2015)  

See also: similar author names
1 Sansano, I.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.